Bora CDMO Bora CDMO

X

Find the latest Drugs in Development and Pipeline Prospector News of Ophirex.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Ophirex
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
5643 Paradise Drive, Suite 2 Corte Madera, CA 94925
Telephone
Telephone
+1 (415) 891-8682
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

Ophirex’s lead drug candidate, LY333013 (varespladib methyl), blocks sPLA2, a nearly ubiquitous and often highly toxic component of venom present in at least 95 percent of snake venoms.


Lead Product(s): Varespladib Methyl

Therapeutic Area: Trauma (Emergency, Injury, Surgery) Product Name: LY333013

Highest Development Status: Phase IIProduct Type: Small molecule

Partner/Sponsor/Collaborator: AXA IM Prime Impact Master Fund

Deal Size: $37.0 million Upfront Cash: Undisclosed

Deal Type: Series B Financing January 05, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY